<html><head><title>EC 2.8.2.23</title></head><base href="http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/8/2/23.html"><body><center><b>IUBMB Enzyme Nomenclature</b><p><h1><b>EC 2.8.2.23</b></h1></center><b>Accepted name</b>: [heparan sulfate]-glucosamine 3-sulfotransferase 1<p><b>Reaction</b>: 3'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine 3',5'-bisphosphate + [heparan sulfate]-glucosamine 3-sulfate<p><b>Glossary:</b> <a href="../../../glossary/PAPS.html">3'-phosphoadenylyl sulfate</a> = PAPS<br>heparan sulfate: for definition <a href="../../../../../iupac/misc/glycp.html#3.2">click here</a><p><b>Other name(s):</b> heparin-glucosamine 3-<i>O</i>-sulfotransferase; 3'-phosphoadenylyl-sulfate:heparin-glucosamine 3-<i>O</i>-sulfotransferase; glucosaminyl 3-<i>O</i>-sulfotransferase; heparan sulfate <small>D</small>-glucosaminyl 3-<i>O</i>-sulfotransferase; isoform/isozyme 1 (3-OST-1, HS3ST1)<p><b>Systematic name</b>: 3'-phosphoadenylyl-sulfate:[heparan sulfate]-glucosamine 3-sulfotransferase<p><b>Comments</b>: This enzyme differs from the other [heparan sulfate]-glucosamine 3-sulfotransferases [<a href="29.html">EC 2.8.2.29</a> ([heparan sulfate]-glucosamine 3-sulfotransferase 2) and <a href="30.html">EC 2.8.2.30</a> ([heparan sulfate]-glucosamine 3-sulfotransferase 3)] by being the most selective for a precursor of the antithrombin-binding site. It has a minimal acceptor sequence of: &rarr; GlcNAc6<i>S</i>&rarr; GlcA&rarr; GlcN2<i>S</i>*&plusmn;6<i>S</i>&rarr; IdoA2<i>S</i>&rarr; GlcN2<i>S</i>&rarr; , the asterisk marking the target (symbols as in <a href="../../../../../iupac/2carb/38.html">2-Carb-38</a> using &plusmn; to mean the presence or absence of a substituent, and &gt; to separate a predominant structure from a minor one. Thus Glc(N2<i>S</i>&gt;NAc) means a residue of glucosamine where the N carries a sulfo group mainly but occasionally an acetyl group.) [1-4]. It can also modify other precursor sequences within heparan sulfate but this action does not create functional antithrombin-binding sites. These precursors are variants of the consensus sequence: &rarr; Glc(N2<i>S</i>&gt;NAc)&plusmn;6<i>S</i>&rarr; GlcA&rarr; GlcN2<i>S</i>*&plusmn;6<i>S</i>&rarr; GlcA&gt;IdoA&plusmn;2<i>S</i>&rarr; Glc(N2<i>S</i>/NAc)&plusmn;6<i>S</i>&rarr; [5]. If the heparan sulfate substrate lacks 2-<i>O-</i>sulfation of GlcA residues, then enzyme specificity is expanded to modify selected glucosamine residues preceded by IdoA as well as GlcA [6].<p><b>Links to other databases</b>:<a target="new" href="http://www.brenda-enzymes.org/enzyme.php?ecno=2.8.2.23">BRENDA</a>, <a target="new" href="http://enzyme.expasy.org/EC/2.8.2.23">EXPASY</a>, <a target="new" href="http://www.genome.ad.jp/dbget-bin/www_bget?ec:2.8.2.23">KEGG</a>, <a target="new" href="http://www.metacyc.org/META/NEW-IMAGE?type=EC-NUMBER&object=EC-2.8.2.23">Metacyc</a>,<a target="new" href="http://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/enzymes/GetPage.pl?ec_number=2.8.2.23">PDB</a>, CAS registry number: 183257-54-7<p><b>References</b>:<p>1. Kusche, M., Backstr&ouml;m, G., Riesenfeld, J., Pepitou, M., Choay, J. and Lindahl, U. Biosynthesis of heparin. <i>O</i>-Sulfation of the antithrombin-binding region. <i>J. Biol. Chem</i>. 263 (1988) 15474-15484. [PMID: <a target="new" href="http://www.ncbi.nlm.nih.gov/pubmed/3139669?dopt=Abstract">3139669</a>]<p>2. Shworak, N.W., Fritze, L.M.S., Liu, J., Butler, L.D. and Rosenberg, R.D. Cell-free synthesis of anticoagulant heparan sulfate reveals a limiting activity which modifies a nonlimiting precursor pool. <i>J. Biol. Chem.</i> 271 (1996) 27063-27071. [PMID: <a target="new" href="http://www.ncbi.nlm.nih.gov/pubmed/8900197?dopt=Abstract">8900197</a>]<p>3. Liu, J., Shworak, N.W., Fritze, L.M.S., Edelberg, J.M. and Rosenberg, R.D. Purification of heparan sulfate <small>D</small>-glucosaminyl 3-<i>O</i>-sulfotransferase. <i>J. Biol. Chem.</i> 271 (1996) 27072-27082. [PMID: <a target="new" href="http://www.ncbi.nlm.nih.gov/pubmed/8900198?dopt=Abstract">8900198</a>]<p>4. Shworak, N.W., Liu, J., Fritze, L.M.S., Schwartz, J.J., Zhang, L., Logeart, D. and Rosenberg, R.D. Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate <small>D</small>-glucosaminyl 3-<i>O</i>-sulfotransferase. <i>J. Biol. Chem.</i> 272 (1997) 28008-28019. [PMID: <a target="new" href="http://www.ncbi.nlm.nih.gov/pubmed/9346953?dopt=Abstract">9346953</a>]<p>5. Zhang, L., Yoshida, K., Liu, J. and Rosenberg, R.D. Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells. <i>J. Biol. Chem.</i> 274 (1999) 5681-5691 [PMID: <a target="new" href="http://www.ncbi.nlm.nih.gov/pubmed/10026187?dopt=Abstract">10026187</a>]<p>6. Zhang, L., Lawrence, R., Schwartz, J.J., Bai, X., Wei., G, Esko, J.D. and Rosenberg, R.D. The effect of precursor structures on the action of glucosaminyl 3-<i>O-</i>sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate. <i>J. Biol. Chem.</i> 276 (2001) 28806-28813. [PMID: <a target="new" href="http://www.ncbi.nlm.nih.gov/pubmed/11375390?dopt=Abstract">11375390</a>]<p><center><small>[EC 2.8.2.23 created 1992, modified 2001]</small></center><p><hr>Return to <a href="../2/">EC 2.8.2 home page</a><br>Return to <a href="../">EC 2.8 home page</a><br>Return to <a href="../../">EC 2 home page</a><br>Return to <a href="../../../">Enzymes home page</a><br>Return to <a href="../../../../">IUBMB Biochemical Nomenclature home page</a><p></body></html>